Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Charles Cerf.
European Journal of Cardio-Thoracic Surgery | 2014
Edouard Sage; Sacha Mussot; G. Trebbia; Philippe Puyo; Marc Stern; Philippe Dartevelle; Alain Chapelier; Marc Fischler; Pierre Bonnette; Delphine Mitilian; P. Puyo; Nicolas Salley; E. Sage; A. Chapelier; S. De Miranda; D. Grenet; A. Hamid; C. Picard; A. Roux; M. Stern; Julie Bresson; Virginie Dumans-Nizard; J.L. Dumoulin; S. Ghiglione; S. Jacqmin; M. Le Guen; L. Ley; Ngai Liu; Jean-Yves Marandon; Mireille Michel-Cherqui
OBJECTIVES Only 15% of brain death donors are considered suitable for lung transplantation (LTx). The normothermic ex vivo lung perfusion technique is used to potentially increase the availability of high-risk lung donors. We report our experience of LTx with initially rejected donors after ex vivo lung reconditioning (EVLR). METHODS From April 2011 to May 2013, we performed EVLR for 32 pairs of donor lungs deemed unsuitable for transplantation and rejected by the 11 French lung transplant teams. After EVLR, lungs with acceptable function were transplanted. During the same period, 81 double-lung transplantations (DLTx) were used as controls. RESULTS During EVLR, 31 of 32 donor lungs recovered physiological function with a median PO2/FiO2 ratio increasing from 274 (range 162-404) mmHg to 511 (378-668) mmHg at the end of EVLR (P < 0.0001). Thirty-one DLTx were performed. The incidence of primary graft dysfunction 72 h after LTx was 9.5% in the EVLR group and 8.5% in the control group (P = 1). The median time of extubation, intensive care unit and hospital lengths of stay were 1, 9 and 37 days in the EVLR group and 1 (P = 0.17), 6 (P = 0.06) and 28 days (P = 0.09) in the control group, respectively. Thirty-day mortality rates were 3.3% (n = 1) in the EVLR group and 3.7% (n = 3) in the control group (P = 0.69). One-year survival rates were 93% in the EVLR group and 91% in the control group. CONCLUSIONS EVLR is a reliable and repeatable technique that offers a significant increase of available donors. The results of LTx with EVLR lungs are similar to those obtained with conventional donors.
Journal of Heart and Lung Transplantation | 2018
G. Trebbia; E. Sage; M. Le Guen; A. Roux; A Soummer; Philippe Puyo; F. Parquin; Marc Stern; T. Pham; S.G Sakka; Charles Cerf
BACKGROUND Single transpulmonary thermodilution (SD) with extravascular lung water index (EVLWI) could become a new tool to better assess lung graft edema during ex-vivo lung perfusion (EVLP). In this study we compare EVLWI with conventional methods to better select lungs during EVLP and to predict post-transplant primary graft dysfunction (PGD). METHODS We measured EVLWI, arterial oxygen/fraction of inspired oxygen (P/F) ratio, and static lung compliance (SLC) during EVLP in an observational study. At the end of EVLP, grafts were accepted or rejected according to a standardized protocol blinded to EVLWI results. We compared the respective ability of EVLWI, P/F, and SLC to predict PGD. Mann-Whitney U-test, Fishers exact test, and receiver-operating characteristic (ROC) curve data were used for analysis. p < 0.05 was considered statistically significant. RESULTS Thirty-five lungs were evaluated by SD during EVLP. Three lungs were rejected for pulmonary edema. Thirty-two patients were transplanted, 8 patients developed Grade 2 or 3 PGD, and 24 patients developed Grade 0 or 1 PGD. In contrast to P/F ratio, SLC, and pulmonary artery pressure, EVLWI differed between these 2 populations (p < 0.001). The area under the ROC for EVLWI assessing Grade 2 or 3 PGD at the end of EVLP was 0.93. Donor lungs with EVLWI >7.5 ml/kg were more likely associated with a higher incidence of Grade 2 or 3 PGD at Day 3. CONCLUSIONS Increased EVLWI during EVLP was associated with PGD in recipients.
Journal of Heart and Lung Transplantation | 2013
G. Trebbia; Edouard Sage; Elie Fadel; Samir G. Sakka; Charles Cerf
Journal of Cardiothoracic and Vascular Anesthesia | 2012
Morgan Le Guen; G. Trebbia; Edouard Sage; Charles Cerf; Marc Fischler
BJA: British Journal of Anaesthesia | 2016
Marie-Louise Felten; Jean-Denis Moyer; Jean-François Dreyfus; Jean-Yves Marandon; E. Sage; A. Roux; F. Parquin; Charles Cerf; B Zuber; M. Le Guen; Marc Fischler
american thoracic society international conference | 2011
Flora Crockett; Hervé Mal; Marc Stern; Elisabeth Rivaud; Charles Cerf; Emmanuel Matthieu; Patrick Honderlick; Karima Amazzough; Antoine Scherrer; Louis Jean Couderc
Journal of Heart and Lung Transplantation | 2018
M. Godement; J. Fessler; E. Sage; A. Roux; Charles Cerf; Romain Pirracchio; Marc Fischler; M. Le Guen
Journal of Heart and Lung Transplantation | 2018
J. Thes; J. Fessler; Romain Pirracchio; A. Roux; E. Sage; Charles Cerf; Marc Fischler; M. Le Guen
European Respiratory Journal | 2016
Annefleur Maignant; François Mellot; Luc Haudebourg; Hélène Neveu; Elisabeth Rivaud; Emilie Catherinot; Camille Bron; Hélène Salvator; Alexandre Chabrol; Oana Anitei; G. Trebbia; J. Devaquet; Charles Cerf; Louis-Jean Couderc; Colas Tcherakian
Journal of Heart and Lung Transplantation | 2014
L. Beaumont; E. Sage; F. Parquin; D. Grenet; S. De Miranda; A. Hamid; C. Picard; Marc Fischler; Charles Cerf; Marc Stern; A. Roux